The insider selling is routine in size and pattern, with all sales tied to option exercises. No bearish signal. Monitor for any upcoming earnings or guidance changes, but this cluster alone does not warrant a trading action.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Aug 25 $614.06entry
- T+1 · 3mo ago +0.81%α +0.79% · $619.05
- T+5 · 3mo ago −5.02%α −4.48% · $583.21
- T+20 · 8w ago +0.50%α +0.26% · $617.15
- T+58 · todayOpen
- T+60 · tomorrow Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three Medpace insiders, including the CEO and CFO, sold a combined $26.4M in open-market shares over two days. The CEO alone sold $26.3M, representing the bulk of the cluster. While the dollar amount is notable, it represents only ~0.15% of the $17.3B market cap, falling in the modest range. The sales are likely part of routine portfolio diversification and option exercise-related dispositions, not a bearish signal on fundamentals, especially given the lack of any negative corporate filings in the cross-filing context.
Key Financial Metrics
Key Facts
- CEO August J. Troendle sold 42,783 shares for ~$26.3M on Aug 19-20.
- CFO Kevin M. Brady sold 3,400 shares for ~$2.13M on Aug 20.
- Director Fred B. Davenport Jr. sold 7,283 shares for ~$4.41M on Aug 19.
- Director Brian T. Carley sold 5,000 shares for ~$3.04M on Aug 19.
- Total open-market sales: ~$26.4M, representing ~0.15% of $17.3B market cap.
- All sales were preceded or accompanied by option exercises (non-cash events), consistent with routine tax/vesting-related dispositions.
Financial Impact
Total insider selling of $26.4M, or ~0.15% of market cap, is modest and not material to company valuation.
Risk Factors
- Insider selling could accelerate if the stock continues to trade near all-time highs.
- No negative corporate events in the cross-filing context, but any future negative news could amplify the bearish interpretation of these sales.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MEDP-1787645443017 |
Track record
24 reports on MEDP
5 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +11.09% at T+20 after the Dec 4, 2025 report. 5 of 6 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $652.28 Now $648.20 +0.62% settles Nov 17
- Nov 13, 20263d ago SC 13G Neutral 4/10 Entry $653.94 to $648.20 Now $648.20 −0.88% ▼ −0.88% +1.03% vs SPY
- Nov 2, 202614d ago Insider Cluster Bearish 4/10 Entry $663.49 to $656.77 Now $648.20 +2.30% ▲ +1.01% +2.66% vs SPY
- Oct 29, 202618d ago 144 Neutral 2/10 Entry $677.56 to $652.01 Now $648.20 −4.33% ▼ −3.77% −2.00% vs SPY
- Oct 27, 202620d ago 144 Neutral 2/10 Entry $673.79 to $692.68 Now $648.20 −3.80% ▲ +2.80% +2.46% vs SPY
- Oct 26, 202621d ago 144 Neutral 2/10 Entry $673.79 to $692.68 Now $648.20 −3.80% ▲ +2.80% +2.46% vs SPY
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $669.20 to $676.77 Now $648.20 −3.14% ▲ +1.13% +0.42% vs SPY
- Oct 21, 202626d ago 8-K Bullish 6/10 Entry $653.96 to $669.20 Now $648.20 −0.88% ▲ +2.33% +2.85% vs SPY
- Sep 28, 20267w ago SC 13D/A Neutral 4/10 Entry $622.11 to $624.18 Now $648.20 +4.19% ▲ +0.33% +0.54% vs SPY
- Aug 31, 202611w ago Insider Cluster Neutral 2/10 Entry $583.21 to $593.02 Now $648.20 +11.14% ▲ +1.68% +1.24% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers